Our specific focus was on FOXA1 due to its elevated expression among diabetes-related genes within the hormone-receptor-positive breast cancer (HR+ BC) subtype, as determined by gene expression analysis of breast cancer patient tissue samples. Here, FOXA1 is linked to breast cancer.